Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-015302
Filing Date
2014-08-13
Accepted
2014-08-13 17:15:05
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ombp20140630_10q.htm 10-Q 426021
2 EXHIBIT 10.4 ex10-4.htm EX-10 205302
3 EXHIBIT 10.5 ex10-5.htm EX-10 55997
4 EXHIBIT 31.1 ex31-1.htm EX-31 10784
5 EXHIBIT 32.1 ex32-1.htm EX-32 6182
  Complete submission text file 0001437749-14-015302.txt   2885010

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS ombp-20140630.xml EX-101.INS 276338
7 EXHIBIT 101.SCH ombp-20140630.xsd EX-101.SCH 30690
8 EXHIBIT 101.CAL ombp-20140630_cal.xml EX-101.CAL 11539
9 EXHIBIT 101.DEF ombp-20140630_def.xml EX-101.DEF 159741
10 EXHIBIT 101.LAB ombp-20140630_lab.xml EX-101.LAB 224638
11 EXHIBIT 101.PRE ombp-20140630_pre.xml EX-101.PRE 155645
Mailing Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525
Business Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525 970-237-5178
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-52530 | Film No.: 141038470
SIC: 2836 Biological Products, (No Diagnostic Substances)